GEHC · NASDAQ
GE HealthCare Technologies Inc.
$71.45 +0.04 (+0.06%)
Company overview
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, and X-ray systems, as well as women's health products.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Exchange
- NASDAQ
- Market cap
- $32.3B
- Employees
- 53,000
- Headquarters
- Chicago, IL
- Website
- gehealthcare.com
- CEO
- Peter J. Arduini
- Listed
- December 15, 2022
- P/E
- 21.65
- Dividend yield
- 0.22%
Company financials
- Revenue
- $20B
- Gross profit
- $8.5B
- Operating income
- $2.5B
- EBITDA
- $3.2B
- Net income
- $1.5B
- EPS
- $3.30
- Total assets
- $37.1B
- Total debt
- $10.6B
- Gross margin
- 42.55%
- Net margin
- 7.54%
- Earnings yield
- 4.62%
Showing FY 2025
GEHC
1D
NASDAQ
O69.33H71.70L69.31C71.42+2.41 (+3.49%)Vol3.13M